Table 2.
The characteristics of patients with and without CRBSI.
| Characteristics | N | Infected group (n = 58) | Noninfected group (n = 238) | t/χ2 | P |
|---|---|---|---|---|---|
| Age (years) | 49.12 ± 9.93 | 48.53 ± 8.16 | 0.833 | 0.402 | |
| Sex (N, %) | 2.539 | 0.111 | |||
| Male | 156 | 36 (62.07) | 120 (50.42) | ||
| Female | 140 | 22 (37.93) | 118 (49.58) | ||
| Protopathy (N, %) | 0.781 | 0.941 | |||
| Chronic glomerulonephritis | 76 | 14 (24.13) | 62 (26.05) | ||
| Diabetic nephropathy | 85 | 17 (29.31) | 68 (28.57) | ||
| Hypertensive nephropathy | 112 | 21 (36.21) | 91 (38.24) | ||
| Nephrotic syndrome | 7 | 2 (3.45) | 5 (2.10) | ||
| Others | 16 | 4 (6.90) | 12 (5.04) | ||
| Cathetering site (N, %) | 0.108 | 0.743 | |||
| Jugular vein | 230 | 46 (79.31) | 184 (77.31) | ||
| Femoral vein | 66 | 12 (20.69) | 54 (22.69) | ||
| Catheter type (N, %) | 5.466 | 0.019 | |||
| Long-term catheter | 192 | 30 (51.72) | 162 (68.07) | ||
| Temporary catheter | 104 | 28 (48.28) | 76 (31.93) | ||
| Cathetering days (N, %) | 0.212 | 0.645 | |||
| <28 days | 181 | 37 (63.79) | 144 (60.50) | ||
| ≥28 days | 115 | 21 (36.21) | 94 (39.50) | ||
| Dialysis time (N, %) | 3.744 | 0.053 | |||
| <1 years | 223 | 38 (65.52) | 185 (77.74) | ||
| ≥1 years | 73 | 20 (34.48) | 53 (22.26) | ||
| Whether use immunosuppressants (N, %) | 0.022 | 0.883 | |||
| No | 269 | 53 (91.38) | 216 (90.76) | ||
| Yes | 27 | 5 (8.62) | 22 (9.24) |